Trevi Therapeutics stock hits all-time high at 11.11 USD
PositiveFinancial Markets

Trevi Therapeutics has reached an all-time high stock price of 11.11 USD, marking a significant milestone for the company. This surge reflects growing investor confidence and interest in Trevi's innovative therapies, which could lead to increased funding and expansion opportunities. Such a performance not only boosts the company's market presence but also highlights the potential for future growth in the biotech sector.
— Curated by the World Pulse Now AI Editorial System






